Primary sclerosing cholangitis
The epidemiology of PSC has been updated to reflect further recent studies, including new data on an increased prevalence of Crohn’s disease in PSC than previously recognised. There is further data to support the use of ursodeoxycholic acid in PSC, though not in high doses, and the section on IgG4-associated cholangitis (IAC) has been expanded due to the publication of multiple trials in this area and the increasing recognition of the importance of IAC as a differential diagnosis in PSC. Additonal important references have been added to the “Further Reading” section, including a new Genome Wide Association Study in PSC.
A relevant case history from Oxford Case Histories in Gastroenterology and Hepatology has been added to this chapter.
Oxford Medicine requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.